Carbamazepine NDC 70518-2426

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-2426Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-2426Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-2426-0	70518242600	100 POUCH in 1 BOX (70518-2426-0) / 1 TABLET, CHEWABLE in 1 POUCH (70518-2426-1)Marketed from Nov 18, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carbamazepine
Generic name (nonproprietary): carbamazepine
Active ingredients: Carbamazepine — 100 mg/1
Dosage form: Tablet, Chewable
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075687
Marketing start: Nov 18, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A2 Inducers (Mechanism)Cytochrome P450 2B6 Inducers (Mechanism)Cytochrome P450 2C19 Inducers (Mechanism)Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 70518-2426_574bfb74-8dce-8cc7-e063-6294a90ac726SPL ID 574bfb74-8dce-8cc7-e063-6294a90ac726SPL set ID 9471b7fb-29d3-4009-9d0f-f20c27351db5RxCUI 308973UNII 33CM23913M
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518242600 followed by a unit qualifier and the quantity

Package 70518-2426-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 23, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS, General ). Trigeminal Neuralgia Car…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075687

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075687
Product	Strength	Form · route	Labeler	Product NDC
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8125
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	Sun Pharmaceutical Industries, Inc.	51672-4041
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	Golden State Medical Supply, Inc.	60429-934
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	REMEDYREPACK INC.	70518-1433
Carbamazepine	Carbamazepine 200 mg/1	Tablet, ChewableOral	Sun Pharmaceutical Industries, Inc.	51672-4050